Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.64
-0.07 (-1.14%)
Aug 14, 2025, 1:43 PM - Market open
Recursion Pharmaceuticals (RXRX) Revenue by Segment
History
| Date | Operating | Grant |
|---|---|---|
| Jun 30, 2025 | 64.51M | 95.00K |
| Mar 31, 2025 | 59.82M | 278.00K |
| Dec 31, 2024 | 58.49M | 618.00K |
| Sep 30, 2024 | 64.60M | 1.01M |
| Jun 30, 2024 | 48.62M | 1.00M |
| Mar 31, 2024 | 45.23M | 699.11K |
| Dec 31, 2023 | 43.88M | 453.11K |
| Sep 30, 2023 | 46.93M | 56.11K |
| Jun 30, 2023 | 49.88M | 88.11K |
| Mar 31, 2023 | 46.52M | 122.00K |
| Dec 31, 2022 | 39.68M | 150.00K |
| Sep 30, 2022 | 28.51M | 178.00K |
| Jun 30, 2022 | 17.95M | 285.00K |
| Mar 31, 2022 | 12.80M | 414.00K |
| Dec 31, 2021 | 10.00M | 551.00K |
| Sep 30, 2021 | 10.05M | 549.00K |
| Jun 30, 2021 | 8.41M | - |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.